ToolGen Incorporated (199800.KQ)
KOSDAQ · KRW · Healthcare · Biotechnology
₩28,050 (+0.72%) as of
Key statistics
- Market cap
- 274.11B
- Dividend yield
- 0.00%
- 52-week range
- 27,250.00 – 142,000.00
- Beta
- 1.17
- Revenue (TTM)
- 1.83B
- Profit margin
- 0.00%
- Volume
- 9.42k
About ToolGen Incorporated
ToolGen Incorporated, a biotechnology company, focuses on the development of genome editing technology in South Korea. The company develops clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene scissors for gene editing in eukaryotic cells. It is involved in patent monetization, treatment, and seed businesses. ToolGen Incorporated was founded in 1999 and is based in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Seoul, South Korea
- Employees
- 65
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.